Finance

Beta
Lists
BMHS:IDX
Bundamedik Tbk PT
IDR 176.00
+1.15%
(+2.00) 1D
Jul 8, 4:14:24 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for BMHS...
Open
IDR 176
High
IDR 185
Low
IDR 172
Mkt. cap
1.51T
Avg. vol.
906.93K
Volume
2.55M
Dividend
0.59%
Quarterly dividend
IDR 0
Ex-dividend date
Jun 10, 2024
P/E ratio
160.99
52-wk high
IDR 246
52-wk low
IDR 143
EPS
IDR 1
Shares outstanding
8.60B
No. of employees
2K
Open
IDR 176
High
IDR 185
Low
IDR 172
Mkt. cap
1.51T
Avg. vol.
906.93K
Volume
2.55M
Dividend
0.59%
Quarterly dividend
IDR 0
Ex-dividend date
Jun 10, 2024
P/E ratio
160.99
52-wk high
IDR 246
52-wk low
IDR 143
EPS
IDR 1
Shares outstanding
8.60B
No. of employees
2K
News stories
From sources across the web
About Bundamedik Tbk PT
CEO-
Employees1.79K
Founded1961
Headquarters-
SectorHealth care provider
Websitebmhs.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
378.77B
397.09B
459.45B
371.09B
Cost of goods sold
209.61B
208.13B
257.96B
204.95B
Cost of revenue
209.61B
208.13B
257.96B
204.95B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
152.20B
155.81B
152.06B
148.52B
Operating expense
156.23B
157.89B
173.28B
152.70B
Total operating expenses
365.84B
366.02B
431.24B
357.65B
Operating income
12.93B
31.07B
28.21B
13.45B
Other non operating income
-1.57B
-1.93B
2.11B
-1.81B
EBT including unusual items
1.72B
17.81B
19.15B
143.96M
EBT excluding unusual items
1.72B
17.81B
18.94B
143.96M
Income tax expense
422.37M
4.17B
9.49B
36.62M
Effective tax rate
24.55%
23.43%
49.53%
25.43%
Other operating expenses
4.03B
2.08B
21.21B
4.17B
Net income
630.30M
8.35B
170.33M
65.72M
Net profit margin
0.17%
2.10%
0.04%
0.02%
Earnings per share
-
-
-
-
Interest and investment income
5.05B
4.53B
7.77B
4.51B
Interest expense
-14.69B
-15.86B
-19.15B
-16.00B
Net interest expenses
-9.64B
-11.34B
-11.38B
-11.50B
Depreciation and amortization charges
-
-
-
-
EBITDA
35.04B
55.77B
37.74B
33.82B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer